Sitemap

• Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone di Palermo (AOUP)
• Contact us:
• High Level Event – 11th May 2017 – Brussels
• MTBVACN3 Projectmeeting – Madagascar
• MTBVACN3 Annual Project Meeting 26-30 May 2024
• Partners
• Press release BIOFABRI and BHARAT BIOTECH
• Press release BIOFABRI and BHARATBIOTECH
• Registration for TBVI meeting in Les Diablerets, Switzerland
• Registration Kick off meeting MTBVACN3 in Spain from10 – 12 May 2020
• Registration MTBVAC in Newborns meeting – Madagascar – 27-28 May 2020
• Registration MTBVAC in Newborns meeting – Senegal
• Registration TBVI annual meeting April 2022
• Registration TBVI annual meeting Les Diablerets 2018
• Registration TBVI annual meeting Les Diablerets 2019
• Registration TBVI meeting in Les Diablerets 2020
• Registration TBVI symposium Les Diablerets 2024
• Registration Workshop 8 October 2019 in Brussels: “Maintaining European scientific excellence and global leadership in TB Vaccine R&D”
• TBVI Annual meeting 3 – 6 April 2023 – Les Diablerets, Switzerland
• TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe – Les Diablerets, Switzerland
• TBVI meeting 2022 – Les Diablerets, Switzerland
• Vacancy Project Manager at SATVI – Cape Town, South Africa
• World TB day 2018
• Home
• Centre National de la Recherche Scientifique – CNRS
• ETH-Zürich – Institute of Molecular Systems Biology
• Friedrich-Loeffler-Institute
• About us
  • TBVI at a glance
  • Mission
  • Organisation
    • Advisory Committee
    • Steering Committee
    • Operational Office
    • Product and Clinical Development Team
    • Governance Board
  • TBVI consortium
  • Key achievements and impact
  • Financials
  • Policies
• Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)
• Imperial College – TB research group Section for Paediatrics
• What we do
  • Pipeline of vaccines
  • Research & Development
  • Services
• International Tuberculosis Research Center (ITRC)
• IRCCS Lazzaro Spallanzani
• How we work
  • Business model
  • Partnership
• Medical Research Council – The Gambia Unit
• NIBSC/MHRA
• SATVI – University of Cape Town
• Scientific Institute for Public Health (WIV-ISP)
• Statens Serum Institute
• Stellenbosch University
• Projects
  • For researchers and vaccine developers
    • Partners pages
    • Access to services
  • ITHEMYC
    • Consortium partners
    • News and Publications
    • Project overview
  • MTBVAC in Newborns
    • Communication tools
    • News and Publications
    • Coordinator and partners
  • MTBVACN3
    • Acknowledgement
    • Governance
    • Publications and news
    • The consortium and its partners
    • Work packages
  • TBVAC-HORIZON
    • Word from the chairs
    • Project overview
    • Consortium partners
    • Advisory Boards
    • Publications and News
  • TBVAC2020
    • Word from the chair
    • TBVAC2020 project overview and achievements
    • TBVAC2020 project members
    • TBVAC2020 scientific publications
    • TBVAC2020 other publications
• Université Libre de Bruxelles
• University Hospital of Ulm
• University of Cape Town
• University of Lausanne, Vaccine Formulation Laboratory
• University of Oxford, the Jenner Institute
• University of Sydney
• University of Zaragoza
• Yonsei University College of Medicine
• News & events
  • News
• TBVI R&D priorities and funding opportunities
• TBVI service provision and funding opportunities
• Why invest in TBVI